BridgeMD
New treatment option for Cancer
Official title On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety
ClinicalTrials.gov ID: NCT07305740
What this study is testing
- What it's testing
- This study is evaluating On-Trac (Online Training After Cancer), an online educational intervention to teach adult cancer survivors strategies to address anxiety based on Cognitive-Behavioral Therapy (CBT) and Acceptance Commitment Therapy (ACT) The name of the study intervention is Online Training After Cancer (On-Trac)
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥ 18
- A diagnosis of cancer (except non-melanoma skin cancer) ≥ 12 months prior.
- No active cancer therapy (excluding chemoprevention) in the past 4 months, and no further therapy planned.
- Significant anxiety as evidenced by both of the following
- Endorsement of the SCID ( Structured Clinical Interview for the DSM-5) Screener Items for Social Anxiety Disorder, Generalized Anxiety Disorder...
You likely can't join if
- Significant symptoms of Panic Disorder in the prior month, including anticipatory anxiety of having a future panic attack or avoidance symptoms...
- Significant symptoms of Obsessive Compulsive Disorder, as evidenced by any obsessions over the past 3 months, as assessed by three SCID items from...
- Psychiatric hospitalizations or emergency room visits for psychiatric care in the prior 2 years.
- In the next two months, intention to use or likelihood of using emergent or "rescue" anxiety medication (e.g., Ativan, Xanax, Valium) or...
- Any significant marijuana use which could impact anxiety symptoms, as evidenced by one of the following:
- 4 days of marijuana use in any week in the last month
See the full eligibility criteria
- Age ≥ 18
- A diagnosis of cancer (except non-melanoma skin cancer) ≥ 12 months prior.
- No active cancer therapy (excluding chemoprevention) in the past 4 months, and no further therapy planned.
- Significant anxiety as evidenced by both of the following
- Endorsement of the SCID ( Structured Clinical Interview for the DSM-5) Screener Items for Social Anxiety Disorder, Generalized Anxiety Disorder, Agoraphobia, Specific Phobia, or Illness Anxiety Disorder.
- A score ≥ 6 on the Overall Anxiety Severity and Impairment Scale (OASIS).
- Regular access to the internet.
- Ability to read and write in English.
- Significant symptoms of Panic Disorder in the prior month, including anticipatory anxiety of having a future panic attack or avoidance symptoms associated with panic attacks, as assessed by three SCID-5 items from the...
- Significant symptoms of Obsessive Compulsive Disorder, as evidenced by any obsessions over the past 3 months, as assessed by three SCID items from the Obsessive Compulsive Disorder module.
- Psychiatric hospitalizations or emergency room visits for psychiatric care in the prior 2 years.
- In the next two months, intention to use or likelihood of using emergent or "rescue" anxiety medication (e.g., Ativan, Xanax, Valium) or self-prescribed substances (i.e., marijuana) at the onset of anxiety symptoms or...
- Any significant marijuana use which could impact anxiety symptoms, as evidenced by one of the following:
- 4 days of marijuana use in any week in the last month
- 20 milligrams of THC (Tetrahydrocannabinol) products in any week in the last month.
- Participation in any CBT or ACT-based behavioral or education intervention for anxiety in the past 2 years. This includes in-person, asynchronous, and synchronous online anxiety programs, and therapy that includes these...
- Any impairment (e.g., hearing, visual, cognitive) that interferes with the ability to complete all parts of the study independently.
The study team makes the final eligibility decision.
Where it's taking place
- Boston, Massachusetts, United States
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Boston, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.